Helmut Uphoff Matthias An der Heiden Brunhilde Schweiger Hartmut Campe Dietmar Beier Carina Helmeke Martina Littmann Walter Haas Silke Buda Daniel Faensen Marcel Feig Doris Altmann Ole Wichmann Tim Eckmanns Udo Buchholz
10.1371/journal.pone.0019932
PLoS One
2011;6(7):e19932.
CC BY
https://pubmed.ncbi.nlm.nih.gov/21789163/
Adjuvants, Immunologic / therapeutic use Influenza A Virus, H1N1 Subtype / immunology Influenza Vaccines / therapeutic use Influenza, Human / drug therapy Influenza, Human / immunology Pandemics / prevention & control
Adjuvants, Immunologic / therapeutic use Influenza A Virus, H1N1 Subtype / immunology Influenza Vaccines / therapeutic use Influenza, Human / drug therapy Influenza, Human / immunology Pandemics / prevention & control Comparative Study Adolescent Adult Age Distribution Aged Aged, 80 and over Case-Control Studies Child Child, Preschool Female Germany / epidemiology Humans Infant Infant, Newborn Influenza Vaccines / immunology Influenza, Human / epidemiology Influenza, Human / virology Logistic Models Male Middle Aged Multivariate Analysis Treatment Outcome Vaccination Young Adult Adjuvants, Immunologic Influenza Vaccines
PMC3138735
21789163
Effectiveness of the AS03-adjuvanted vaccine against pandemic influenza virus A/(H1N1) 2009--a comparison of two methods; Germany, 2009/10
2011